All Insights
Showing 1 - 12 of 276
Life Sciences and Healthcare
Is the MHRA creating the right conditions to encourage UK investment in AI products?
Businesses bringing AI to market need to be aware of public policy and commercial factors driving regulatory reform
Life Sciences and Healthcare
EU enforces stricter liability for life sciences products
Pharma and medtech companies face enhanced liability under the EU's new directive
Tax
Spanish Supreme Court clarifies the binding nature of the report of the Ministry of Science and Innovation in order to apply tax deduction for technological innovation
Spanish Supreme Court annuls National High Court decisions regarding tax deduction for technological innovation
Life Sciences and Healthcare
Medtech sector faces new EU 'green deal' recommendations
Greener medical devices and processes are among MedTech Europe's recommendations for business sustainability
Life Sciences and Healthcare
Investment control in transactions in the life sciences and healthcare sector
Investment control means that additional regulatory approvals are required, affecting the timeline, complexity and costs of a transaction
Life Sciences and Healthcare
Life sciences dealmakers need to anticipate sector-specific factors in European M&A
European regulatory and intellectual property complexities must be addressed when engaging in mergers and acquisitions
Life Sciences and Healthcare
UK government to refresh post-market surveillance requirements for medical devices
New regulations introduced to bring the UK regulatory framework closer in line with international best practice for post-market surveillance requirements
The UK Budget
What do venture capitalists need to know about the UK government's policies?
Tax changes and growth plans pose opportunities and challenges for the venture capital community
Regulatory and compliance
What can UK business expect from regulators in future?
What can be learnt from the UK government's stated approach to regulation and growth?
The UK Budget
How does the UK Budget impact the life sciences and healthcare sector?
Change is afoot as more NHS investment and reforms follow a new industrial strategy and Regulatory Innovation Office
Life Sciences and Healthcare
EU tightens health tech regulations on supply chain disruptions
European Commission clarifies new rules for 2025, mandating early notification of potential medical device supply issues
Life Sciences and Healthcare
European Parliament urges revision of medical devices regulations
EU medtech and diagnostics sectors face critical regulatory updates in new parliamentary resolution
